Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Plos One|May 26, 2022
Long-term development of lens fluorescence in a twin cohort: Heritability and effects of age and lifestyleJakob Bjerager, Sami Dabbah, Mohamed Belmouhand, et al.
Neurorehabilitation|June 10, 2019
An exploratory investigation of the effect of naturalistic light on depression, anxiety, and cognitive outcomes in stroke patients during admission for rehabilitation: A randomized controlled trialAnders West, Sofie Amalie Simonsen, Alexander Zielinski, et al.
Investigative Ophthalmology & Visual Science|November 26, 2009
Prolonged multifocal electroretinographic implicit times in the ocular ischemic syndromePeter Kristian Kofoed, Inger Christine Munch, Birgit Sander, et al.
Acta Ophthalmologica|March 24, 2009
Axonal loss occurs early in dominant optic atrophyDan Milea, Birgit Sander, Marianne Wegener, et al.
Neurorehabilitation|September 10, 2019
An exploratory investigation of the effect of naturalistic light on fatigue and subjective sleep quality in stroke patients admitted for rehabilitation: A randomized controlled trialAnders West, Sofie Amalie Simonsen, Poul Jennum, et al.
Investigative Ophthalmology & Visual Science|December 17, 2009
Small, hard macular drusen and peripheral drusen: associations with AMD genotypes in the Inter99 Eye StudyInger Christine Munch, Jakob Ek, Line Kessel, et al.
Acta Ophthalmologica|November 22, 2007
Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedemaWael Soliman, Martin Vinten, Birgit Sander, et al.
Acta Ophthalmologica|October 20, 2011
Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatmentSara B Bloch, Morten la Cour, Birgit Sander, et al.
Investigative Ophthalmology & Visual Science|August 29, 2007
Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameterBirgit Sander, Dorte Nellemann Thornit, Lotte Colmorn, et al.
Ophthalmology|July 9, 2013
A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degenerationAnnette Rasmussen, Sara B Bloch, Josefine Fuchs, et al.
Pageof 10